Expression profile and functional analysis of miR-301b in patients with breast cancer: A bioinformatics, biochemical, and histopathological study
Pathology - Research and Practice · 2024
DOI: 10.1016/j.prp.2024.155536 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Mohamed Taha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt. Electronic address: Mohamed.taha@pharma.cu.edu.eg. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms, Computational Biology, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: microRNAs (miRNAs) are crucial regulators of various biological processes and molecular functions. Aberrant miRNA expression has been linked in many studies to neoplastic transformation. Among these miRNAs, dysregulation of miR-301b-5p was associated with different types of cancer including breast cancer. Although many research works have investigated the function of miR-301b in carcinogenesis, few have examined its expression, biological, and clinical implications in breast cancer. METHODS: we examined the expression levels of miR-301b-5p in human cancerous breast tissue compared to normal breast controls using different bioinformatic tools and RT-qPCR analyses. RESULTS: we detected that miR-301b-5p was differentially expressed in cancerous breast tissue when compared to normal controls. MiR-301b-5p was detected to be upregulated in high-grade (Grade 3) and triple-negative breast cancers. A significant strong positive correlation was detected between miR-301b and Ki-67, the commonly used proliferative marker in breast cancer. Bioinformatics analyses using the KM plotter revealed that miR-301b has significant prognostic power in assessing the OS of patients with breast cancer. The study also identified many fundamental biological processes and regulatory pathways associated with the investigated miR-301b-related hub genes. Interestingly, the expression pattern and prognostic significance of PTEN, the top hub gene regulated by miR-301b, highlighted the prognostic significance of PTEN in breast cancer. CONCLUSION: The current study findings suggest the potential use of miR-301b-5p as a possible diagnostic and prognostic biomarker in breast cancer. Moreover, this study emphasized the clinical and biological relevance of miR-301b-5p in breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt. Electronic address: Mohamed.taha@pharma.cu.edu.eg.
- Department of Histology and Cell Biology, Faculty of Medicine, Menoufia University, Shebin Elkom 3251, Egypt.
- Medical Affairs Manager, Surgitech-Egypt.
- College of Medicine, Ras Al khaimah Medical and Health Science University, UAE; Department of Community Medicine, Kasr Al Ainy Faculty of Medicine, Cairo University, Egypt.
- Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.
Zitieren
APA
Taha, M., Yousef, E., Badr, A. N., Salama, R. A., & Maurice, N. (2024). Expression profile and functional analysis of miR-301b in patients with breast cancer: A bioinformatics, biochemical, and histopathological study. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155536
Vancouver
Taha M, Yousef E, Badr AN, Salama RA, Maurice N. Expression profile and functional analysis of miR-301b in patients with breast cancer: A bioinformatics, biochemical, and histopathological study. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155536
BibTeX
@article{Taha2024,
author = {Taha, Mohamed and Yousef, Einas and Badr, Ahmed Nawar and Salama, Rasha A and Maurice, Nadine},
title = {Expression profile and functional analysis of miR-301b in patients with breast cancer: A bioinformatics, biochemical, and histopathological study},
journal = {Pathology - Research and Practice},
year = {2024},
doi = {10.1016/j.prp.2024.155536}
}
EUVIMED